Novo's shares plunged amid rising competition, missed expectations, and governance issues, exposing the risks of neglecting ...

When it was riding high, Novo Nordisk could have done M&A to reduce its dependence on obesity treatments. It didn’t.

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

Denmark’s status as one of the few countries in Europe with an expanding economy rests in part on the success of its ...

Stocks tumbled from record highs on Friday as data revealed the US labor market is not on as solid footing as previously thought. On the week, the S&P 500 (^GSPC) fell nearly 2.4%, while the Nasdaq ...

Trade deficit data, Federal Reserve officials' remarks, earnings from Pfizer, Disney, Uber, and additional companies.